Axcynsis Therapeutics

Website

Developer of antibody-drug conjugate therapies designed for treating cancer. The company's platform leverages proprietary technologies to create antibody-toxin conjugates, enabling healthcare companie...

Healthcare
Singapore, Singapore
Founded 2022
24 employees
Website
Valuation
$36.1M
Market implied
Share Price
N/A
Total Raised
$21M
Last Round
N/A
Investors
+2 other investors
View all 2 investors
Valuation History
0 funding rounds on record
Cap Table
Ownership structure
Market Activity
Secondary transactions

Get the full picture

Create a free account to unlock Axcynsis Therapeutics's funding history, team members, investor details, and more.

15 free profiles/month · No credit card required